
Sign up to save your podcasts
Or


Chris Long was the first patient at MUSC Health to receive the Alzheimer’s drug, Leqembi. Eighteen months on, he’s still golfing, spending time with friends, and feeling hopeful about the future. In this episode, Harvey shares Chris’s story, what his wife and doctors have observed, and the important facts to know if you’re considering this new treatment.
By SandraChris Long was the first patient at MUSC Health to receive the Alzheimer’s drug, Leqembi. Eighteen months on, he’s still golfing, spending time with friends, and feeling hopeful about the future. In this episode, Harvey shares Chris’s story, what his wife and doctors have observed, and the important facts to know if you’re considering this new treatment.